13F Holdings
中文EN

LFMD LifeMD, Inc.

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 948320 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.6%
TTM net income YoY95.6%
TTM EPS YoY91.2%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR—

Margins

Gross margin84.1%
Operating margin-17.9%
Net margin-0.3%
FCF margin-7.5%
EBITDA margin-17.2%

Returns

ROE-125.9%
ROA-0.7%
ROIC (approx.)—
Asset turnover2.26x

Leverage & solvency

Liabilities / assets100.9%
Debt / equity—
Current ratio0.80x
Interest coverage92.33x

Cash quality & payout

Operating cash flow / net income23.16x
Accruals ratio15.5%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$194.06M$154.82M$152.55M$119.03M$92.88M
Cost of revenue$27.71M$21.44M$18.90M$18.67M$18.00M
Gross profit$166.34M$133.38M$133.65M$100.37M$74.88M
SG&A expense$57.94M$57.95M$51.69M$46.96M$39.53M
Operating income-$7.67M-$20.40M-$14.49M-$43.45M-$54.30M
Interest expense$1.36M$2.18M$2.60M$1.28M$3.02M
Pretax income-$10.19M-$22.58M-$17.41M-$44.66M-$61.32M
Income tax$45,721$598,000$428,000$360,700$7,700
Net income$14.35M-$21.41M-$20.60M-$45.54M-$60.90M
EBITDA-$6.80M-$19.94M-$14.29M-$43.29M-$54.29M
EPS (basic)0.25-0.60———
EPS (diluted)0.25-0.60———
Weighted avg. shares (diluted)45.13M41.20M33.91M30.98M27.01M
Balance sheet
Cash & equivalents$36.79M$32.65M$33.15M$3.96M$41.33M
Receivables$2.49M$10.46M$6.27M$2.83M$980,055
Inventory$2.77M$2.80M$2.76M$3.70M$1.62M
Current assets$45.01M$52.37M$42.60M$11.31M$44.92M
PP&E, net$2.44M$1.44M$476,303$476,441$233,805
Goodwill———$8.00M$0
Intangibles$262,334$53,336$3.01M$3.83M$19,761
Total assets$63.59M$76.10M$58.48M$25.67M$49.92M
Current liabilities$39.58M$67.40M$34.78M$31.37M$22.83M
Total liabilities$45.26M$83.65M$52.91M$32.97M$24.10M
Shareholders' equity$18.33M-$9.08M$3.51M-$11.40M$22.74M
Shares outstanding46.66M42.19M38.26M31.45M30.60M
Cash flow statement
Operating cash flow$8.28M$17.51M$8.82M-$22.94M-$33.09M
Capital expenditure$1.87M$1.46M$203,814$366,633$247,365
Free cash flow$6.41M$16.05M$8.62M-$23.30M-$33.33M
Investing cash flow$6.91M-$11.54M-$8.73M-$13.91M-$3.40M
Financing cash flow-$13.41M-$4.12M$29.10M-$528,200$68.64M
Depreciation & amortization$865,524$465,830$203,952$161,885$13,560
Stock-based compensation$10.50M$12.23M$12.49M$13.73M$12.07M
Dividends paid$3.11M$3.11M$3.11M$3.11M$871,476
Share buybacks$270,000————

Free plan shows the latest 5 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.